The Release of Factor Viii and Tissue Plasminogen Activator can not be Blocked by Specific Antagonists to Vasopressin
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptor Research
- Vol. 11 (1-4) , 239-245
- https://doi.org/10.3109/10799899109066403
Abstract
Vasopressin and in particular 1-deamino-8-D-arginine vasopressin (DDAVP) can release factor VIII (FVIII) and tissue plasminogen activator (tPA) to the blood. In the present study DDAVP was injected in conscious dogs which had been preloaded with specific antagonists either against vasopressin's vasopressor response (V1-receptors) or its antidiuretic response (V2-receptors). The presence in the blood of either of the antagonists had no effect on the increase of FVIII or tPA following stimulation with DDAVP. It is therefore concluded that the effect of DDAVP on coagulation and fibrinolysis is elicited via a new class of receptors different from the known V1- and V2-receptors.Keywords
This publication has 5 references indexed in Scilit:
- Plasma concentration of factor VIII after administration of DDAVP of conscious dogsThrombosis Research, 1987
- ABSENT FACTOR VIII RESPONSE TO SYNTHETIC VASOPRESSIN ANALOGUE (DDAVP) IN NEPHROGENIC DIABETES INSIPIDUSThe Lancet, 1985
- Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(.beta.-mercapto-.beta.,.beta.-pentamethylenepropionic acid), 2-D-isoleucine, 4-valine]arginine-vasopressin at position 4Journal of Medicinal Chemistry, 1984
- Association between Factor VIII Related Antigen and Plasminogen ActivatorActa Medica Scandinavica, 1982
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975